Article
Fibrotic chronic eosinophilic pneumonia: from inflammation to fibrosis and therapeutic implications.
European respiratory review : an official journal of the European Respiratory Society - 1 Jul 2026
Previtero Daniele, Castelli Gioele, Padrin Ylenia, Scalvenzi Francesca, Ruzzon Isabella, Cocconcelli Elisabetta, Tinè Mariaenrica, Balestro Elisabetta, Padoan Roberto, Caminati Marco, Baraldo Simonetta, Spagnolo Paolo, Semenzato Umberto
Abstract excerpt
Chronic eosinophilic pneumonia is a rare inflammatory lung disease that typically responds to systemic glucocorticoids but is frequently complicated by relapses and treatment-related toxicity. In recent years, monoclonal antibodies targeting the interleukin-5 (IL-5) pathway have emerged as effective glucocorticoid-sparing therapies in relapsing or glucocorticoid-dependent chronic eosinophilic pneumonia. Alongside...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.